Evidence map›Paper›PMID 17548465›Full record

ArticleMolecular and cellular biology2007

Agm1/Pgm3-mediated sugar nucleotide synthesis is essential for hematopoiesis and development.

Kylie T Greig, Jennifer Antonchuk, Donald Metcalf, Phillip O Morgan, Danielle L Krebs, Jian-Guo Zhang, Douglas F Hacking, Lars Bode, Lorraine Robb, Christian Kranz and 8 more

Open access · greenAbstract read
In one paragraph

Article in Molecular and cellular biology, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed, 1 pooled it
0.3field-weighted citation impact, top 42% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

40 citing papers in PubMed, 1 synthesis or guideline pooled it, 60 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Article
  5. Understanding and Managing Hyper IgE Syndromes.ImmunoTargets and therapy · 2025
    Review
  6. Article
  7. The role of glycosylation in clinical allergy and immunology.The Journal of allergy and clinical immunology · 2024
    Review
  8. Review
  9. Review
  10. Review
  11. Article
  12. Review
  13. SsAGM1-Mediated Uridine Diphosphate-Frontiers in microbiology · 2022
    Article
  14. Review
  15. HeterozygousFrontiers in genetics · 2020
    Article
  16. Article
  17. Article
  18. Article
  19. Human hyper-IgE syndrome: singular or plural?Mammalian genome : official journal of the International Mammalian Genome Society · 2018
    Review
  20. CDG Therapies: From Bench to Bedside.International journal of molecular sciences · 2018
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 3 institutions in 3 countries.

Kylie T GreigDivision of Molecular Medicine, The Walter and Eliza Hall Institute of Medical Research, Victoria, Australia.
Jennifer Antonchuk
Donald Metcalf
Phillip O Morgan
Danielle L Krebs
Jian-Guo Zhang
Douglas F Hacking
Lars Bode
Lorraine Robb
Christian Kranz
Carolyn de Graaf
Melanie Bahlo
Nicos A Nicola
Stephen L Nutt
Hudson H Freeze
Warren S Alexander
Douglas J Hilton
Benjamin T Kile
Walter and Eliza Hall Institute of Medical Research · AUSanford Burnham Prebys Medical Discovery Institute · USUniversity of Melbourne · AU

Funding

Carbohydrate Deficient Glycoprotein Syndromes: Models and TherapyR01DK055615 · NIDDK · SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE · PI FREEZE, HUDSON H. · 1999 to 2013
$4.4M
Differentiation of Granulocytes and MacrophagesR37CA022556 · NCI · WALTER AND ELIZA HALL INST MEDICAL RES · PI METCALF, DONALD · 2005 to 2014
$2.3M
DIFFERENTIATION OF GRANULOCYTES AND MACROPHAGESR01CA022556 · NCI · WALTER AND ELIZA HALL INST MEDICAL RES · PI METCALF, DONALD · 1985 to 2004
$900k
NCI NIH HHS CA22556NCI NIH HHS R01 CA022556NCI NIH HHS R37 CA022556NIDDK NIH HHS R01 DK055615NIDDK NIH HHS R01 DK55615
6 · The paper itself

Abstract

Carbohydrate modification of proteins includes N-linked and O-linked glycosylation, proteoglycan formation, glycosylphosphatidylinositol anchor synthesis, and O-GlcNAc modification. Each of these modifications requires the sugar nucleotide UDP-GlcNAc, which is produced via the hexosamine biosynthesis pathway. A key step in this pathway is the interconversion of GlcNAc-6-phosphate (GlcNAc-6-P) and GlcNAc-1-P, catalyzed by phosphoglucomutase 3 (Pgm3). In this paper, we describe two hypomorphic alleles of mouse Pgm3 and show there are specific physiological consequences of a graded reduction in Pgm3 activity and global UDP-GlcNAc levels. Whereas mice lacking Pgm3 die prior to implantation, animals with less severe reductions in enzyme activity are sterile, exhibit changes in pancreatic architecture, and are anemic, leukopenic, and thrombocytopenic. These phenotypes are accompanied by specific rather than wholesale changes in protein glycosylation, suggesting that while universally required, the functions of certain proteins and, as a consequence, certain cell types are especially sensitive to reductions in Pgm3 activity.

Indexed as

Embryonic DevelopmentHematopoiesisAllelesAnimalsBase SequenceFemaleGlycosylationMaleMiceMice, Inbred BALB CMice, Inbred C57BLMolecular Sequence DataMutationPancreasPhosphoglucomutaseRNA SplicingPgm3 protein, mousePhosphoglucomutaseUridine Diphosphate N-Acetylglucosamine

Identifiers

PMID17548465
PMCPMC1952135
OpenAlexW2029586932

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.